Regencell Bioscience Holdings (RGC) Property, Plant & Equipment (Net) (2020 - 2025)
Regencell Bioscience Holdings (RGC) Property, Plant & Equipment (Net) (2020 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 2.55 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.93 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 3.76 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 13.44 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.93 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 2.44 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 90.50 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 1.41 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | Regencell Bioscience Holdings | 2.61 Bn | 2.61 Bn | - | 176,429.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 176,429.00 |
| Dec 31, 2025 | 176,429.00 |
| Jun 30, 2025 | 215,434.00 |
| Jun 30, 2025 | 215,434.00 |
| Jun 30, 2024 | 141,734.00 |
| Jun 30, 2024 | 141,734.00 |
| Jun 30, 2023 | 440,829.00 |
| Jun 30, 2023 | 440,829.00 |
| Jun 30, 2022 | 712,594.00 |
| Jun 30, 2022 | 712,594.00 |
| Jun 30, 2021 | 81,865.00 |
| Jun 30, 2021 | 81,865.00 |
| Jun 30, 2020 | 108,321.00 |
| Jun 30, 2020 | 108,321.00 |